Connection

THI THANH TAM HUYNH to Animals

This is a "connection" page, showing publications THI THANH TAM HUYNH has written about Animals.
Connection Strength

0.074
  1. Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Surg. 2001 Feb; 33(2):400-7.
    View in: PubMed
    Score: 0.008
  2. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol. 1999 Nov; 17(11):1083-6.
    View in: PubMed
    Score: 0.008
  3. External support modulates G protein expression and receptor coupling in experimental vein grafts. Surgery. 1999 Aug; 126(2):127-34.
    View in: PubMed
    Score: 0.008
  4. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts. J Surg Res. 1999 Jun 15; 84(2):223-32.
    View in: PubMed
    Score: 0.008
  5. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts. J Vasc Surg. 1999 Feb; 29(2):334-44.
    View in: PubMed
    Score: 0.007
  6. Adenoviral-mediated inhibition of G beta gamma signaling limits the hyperplastic response in experimental vein grafts. Surgery. 1998 Aug; 124(2):177-86.
    View in: PubMed
    Score: 0.007
  7. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts. J Surg Res. 1998 Jul 01; 77(2):104-11.
    View in: PubMed
    Score: 0.007
  8. Chronically impaired endothelial vasoreactivity following oversized endovascular introducer sheath placement in porcine iliac arteries: implications for endovascular therapy. Vascular. 2006 Nov-Dec; 14(6):353-61.
    View in: PubMed
    Score: 0.003
  9. Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells reduces neointimal hyperplasia. J Mol Cell Cardiol. 2002 Oct; 34(10):1399-1409.
    View in: PubMed
    Score: 0.002
  10. Vascular endothelial growth factor restores corporeal smooth muscle function in vitro. J Urol. 2001 Apr; 165(4):1310-5.
    View in: PubMed
    Score: 0.002
  11. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts. J Surg Res. 2000 Jul; 92(1):103-7.
    View in: PubMed
    Score: 0.002
  12. Combination therapy of cholesterol reduction and L-arginine supplementation controls accelerated vein graft atheroma. Ann Vasc Surg. 1999 Sep; 13(5):484-93.
    View in: PubMed
    Score: 0.002
  13. Early morphology of accelerated vein graft atheroma in experimental vein grafts. Ann Vasc Surg. 1999 Jul; 13(4):378-85.
    View in: PubMed
    Score: 0.002
  14. Functional characterization of alpha1-adrenergic receptors in experimental vein grafts. J Surg Res. 1999 Jun 01; 84(1):40-5.
    View in: PubMed
    Score: 0.002
  15. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport. Eur J Vasc Endovasc Surg. 1999 Jun; 17(6):493-500.
    View in: PubMed
    Score: 0.002
  16. Local delivery of a tissue factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts. J Surg Res. 1998 Dec; 80(2):164-70.
    View in: PubMed
    Score: 0.002
  17. G protein signaling and vein graft intimal hyperplasia: reduction of intimal hyperplasia in vein grafts by a Gbetagamma inhibitor suggests a major role of G protein signaling in lesion development. Arterioscler Thromb Vasc Biol. 1998 Aug; 18(8):1275-80.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.